Navigation Links
Study: Steroid Abuse in Teens is Increasing; polyDNA Recommends Muxscle for Safe Muscle Building
Date:3/14/2013

Rochester, NY (PRWEB) March 14, 2013

polyDNA has learned that a growing number of teens are abusing anabolic steroids at a young age.

"Men and women are increasingly using illegal steroids in order to build muscle or get toned. New research from the University of Minnesota has found that many teens are abusing steroids at a young age." [1]

Moreover, "We've got some young people and in some cases pretty young, young people we're looking at middle schoolers, who say they are using some of these pretty risky substances in order to increase their muscularity. And that's something we need to be paying attention to." - Marla Eisenberg, lead author of the University of Minnesota study. [2]

Parents should be aware of the serious side effects of anabolic steroids. polyDNA urges parents to speak with their teens about natural alternatives to steroids. One such alternative is Muxscle.

Muxscle is a unique, all natural, and safe bodybuilding supplement which was tested and found to be safe and effective in a clinical study conducted by the Center for the Biology of Chronic Disease. http://www.cbcd.net/CBCD-Abstract-of-Muxscle-Clinical-Study.pdf

Muxscle is not a steroid…synthetic or otherwise. It is natural, and was developed after much research into the best, most effective muscle building and strengthening natural ingredients.

Although polyDNA recognizes that many teens want fast results, Muxscle is not an instant fix.

polyDNA would like to point out that safety is an important concern especially with teenagers, and that building big muscles naturally is the safer option. Muxscle increases physical strength and helps one to gain bigger muscles by stimulating the signal that nerves send to muscles.

The stronger the signal the brain sends to the muscles, the stronger the muscle contraction. The stronger a person’s muscle contractions are, the faster the muscle growth.

Muxscle has been clinically tested by scientists at the Center for the Biology of Chronic Disease (CBCD). The scientists found that it safely increased the overall physical strength of the participants in the study. They also found that it improved the performance of those activities that required the use of physical strength.

A capsule of Muxscle includes 100 mg of quercetin, 150 mg of a green tea extract, 50 mg of a cinnamon extract, 25 mg of a licorice extract, and 100 mcg of selenium. The Muxscle formula is patent protected.

In addition, each bottle is GMP Certified and can be bought from the Muxscle website for just $39.95.

To learn more about Muxscle, and how it can help teens build bigger, stronger muscles safely, visit http://www.muxscle.com.

To schedule an interview with a polyDNA scientist, please call 585-250-9999

References:

[1] [2 http://www.ncbi.nlm.nih.gov/pubmed/23166333

###

polyDNA is a biotechnology company that develops dietary supplements using Dr. Hanan Polansky’s scientific method. Dr. Polansky published the highly acclaimed scientific theory on the relationship between the DNA of latent (chronic) viruses and the onset of chronic disease.

polyDNA developed and is marketing Muxscle, a natural pill that increases physical strength by stimulating the signal that nerves send to muscles.

Read the full story at http://www.prweb.com/releases/2013/3/prweb10522624.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Study: Catheter-based varicose vein treatments more cost-effective
2. Penn study: Financial incentives affect prostate cancer treatment patterns
3. Study: Mega Vitamins Wont Help After Heart Attack, Chelation Treatment Might
4. Study: Diabetic medication may protect patients from developing heart failure
5. Doctors Health Press Reports on German Study: Only 20% of Patients Get Colonoscopies, Important in Preventing and Diagnosing Colon Cancer
6. Bel Marra Health Reports on a New Study: Parents are Much More Likely to Experience Symptoms of Depression and Anxiety
7. Study: HPV Genital Warts is Most Common Sexually Transmitted Infection in U.S. Military, polyDNA Recommends Gene-Eden-VIR Against the HPV Infection
8. Study: Computerized reminders significantly improve HIV care in resource-limited setting
9. New gender benchmarking study: Brazil succeeding in providing a positive STI environment for women
10. Bel Marra Health Reports on a New Study: Software Originally Used for Star Gazing Now Being Used to Analyze Breast Cancer Tissue
11. Study: Same-sex cohabitors less healthy than those in heterosexual marriages
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 26, 2017 , ... Elisabete Miranda, ... been honored by Enterprising Women magazine as one of its 2017 Enterprising Women ... business owners. Winners have demonstrated that they have fast-growth businesses, mentor or actively ...
(Date:4/26/2017)... ... April 26, 2017 , ... RawTrition now brings you BioEnergy which is ... from SUPERFOODS! , RawTrition is taking nutrients to the next level! ... body recognizes its raw form (unlike the synthetically made options that are on the ...
(Date:4/26/2017)... , ... April 26, 2017 , ... ... performance, is proud to announce that it has received 510(k) clearance from the ... MyoCycle Home and the MyoCycle Pro. , Both devices are stationary cycling systems ...
(Date:4/25/2017)... , ... April 25, 2017 ... ... in Newport Beach, California, committed to raising awareness for Duchenne muscular dystrophy, ... from its randomized CAP-1002 (cardiosphere-derived cells) Phase I/II HOPE clinical trial in ...
(Date:4/25/2017)... ... ... The doctors at Wall Centre Dental are now expanding their practice by accepting ... receive dental care. The doctors offer three treatment options to put victims of ... at their dental office in Vancouver. Wall Centre Dental is currently welcoming even patients ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)...  AbbVie (NYSE: ABBV), a global biopharmaceutical company, ... hepatitis C virus (HCV) infected patients with genotype ... cirrhosis (Child-Pugh A) achieved sustained virologic response at ... investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high ... weeks of G/P treatment without ribavirin. Patients with ...
(Date:4/20/2017)... 2017 Research and Markets has announced ... Services Market Analysis By Service (Manufacturing, Research), By Country, (Brazil, ... 2025" report to their offering. ... The Latin American pharmaceutical contract manufacturing services ... Low drug registration cost in Latin American countries ...
(Date:4/19/2017)... VIEW, Calif. , April 19, 2017  IRIDEX ... it will release financial results for the first quarter ... 3, 2017.  The Company,s management team will host a ... 5:30 p.m. ET. Investors interested in listening ... (844) 707-0665 for domestic callers or (703) 326-3030 for ...
Breaking Medicine Technology: